Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation
about
Significance of HbA1c Test in Diagnosis and Prognosis of Diabetic PatientsAlternative biomarkers for assessing glycemic control in diabetes: fructosamine, glycated albumin, and 1,5-anhydroglucitolThe optimal cutoff value of glycated hemoglobin for detection of diabetic retinopathyA cross-sectional analysis of dioxins and health effects in municipal and private waste incinerator workers in JapanNon-communicable diseases in decontamination workers in areas affected by the Fukushima nuclear disaster: a retrospective observational studyUrine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational studyPostnuclear disaster evacuation and chronic health in adults in Fukushima, Japan: a long-term retrospective analysis.Urbanization and prevalence of type 2 diabetes in Southern Asia: A systematic analysis.Update and Next Steps for Real-World Translation of Interventions for Type 2 Diabetes Prevention: Reflections From a Diabetes Care Editors' Expert Forum.Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants.Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studiesFasting plasma glucose concentrations for specified HbA1c goals in Korean populations: data from the Fifth Korea National Health and Nutrition Examination Survey (KNHANES V-2, 2011)The future of population registers: linking routine health datasets to assess a population's current glycaemic status for quality improvementPrevalence of retinopathy and its risk factors in a Japanese populationInvestigation and Analysis of Hemoglobin A1c Measurement Systems' Performance for 135 Laboratories in China.Study of Glycated Haemoglobin (HbA1c) In Non-Diabetic Subjects with Subclinical Hypothyroidism.The change in blood glucose levels in tuberculosis patients before and during anti-tuberculosis treatment in China.Heterogeneity of glycometabolism in patients with gestational diabetes mellitus: Retrospective study of 1,683 pregnant women.Effect and maintenance of the SLIMMER diabetes prevention lifestyle intervention in Dutch primary healthcare: a randomised controlled trialMulticentre evaluation of the Premier Hb9210 HbA1c analyser.Using hemoglobin A1C as a predicting model for time interval from pre-diabetes progressing to diabetes.Diabetes and pre-diabetes as determined by glycated haemoglobin A1c and glucose levels in a developing southern Chinese population.Significance of HbA1c and its measurement in the diagnosis of diabetes mellitus: US experience.Fructosamine is a useful indicator of hyperglycaemia and glucose control in clinical and epidemiological studies--cross-sectional and longitudinal experience from the AMORIS cohort.Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management.High diabetes prevalence among tuberculosis cases in Kerala, India.Association of secreted frizzled-related protein 4 (SFRP4) with type 2 diabetes in patients with stable coronary artery diseaseImportance of weight loss maintenance and risk prediction in the prevention of type 2 diabetes: analysis of European Diabetes Prevention Study RCT.Diabetes mellitus: The epidemic of the century.Is the present cut-point to define type 2 diabetes appropriate in Latin-Americans?Diabetes mellitus in Nigeria: The past, present and future.Changes in glycosylated haemoglobin and treatment outcomes in patients with tuberculosis in Iran: a cohort study.Incidence of type 2 diabetes in Japan: a systematic review and meta-analysisEvaluation of glycated hemoglobin (HbA1c) for diagnosing type 2 diabetes and prediabetes among Palestinian Arab population.Glycated albumin is more closely correlated with coronary artery disease than 1,5-anhydroglucitol and glycated hemoglobin A1cHigh prevalence of diabetes and intermediate hyperglycemia - The Brazilian Longitudinal Study of Adult Health (ELSA-Brasil)Glycaemic control in diabetic patients in ZambiaPrevalence of dyslipidaemia and associated risk factors in a rural population in South-Western Uganda: a community based surveyTrends in prevalence and control of diabetes in the United States, 1988-1994 and 1999-2010.Diabetes Complications at Presentation and One Year by Glycated Haemoglobin at Diagnosis in a Multiethnic and Diverse Socioeconomic Population: Results from the South London Diabetes Study.
P2860
Q26743367-BC217F9D-34C9-4485-8568-CD4013046337Q26801852-07FF20A7-85EF-4D38-B914-B86730A51F2CQ26859260-8B93182B-E8FF-431D-90A7-C1F3DF7E151BQ28390158-9976738D-87DB-4016-9E34-087CCE097D0CQ28396794-06600CA7-7211-45D3-A180-5BA77F191F7AQ28660810-0614B742-E551-4CA2-9468-D4B0DFA4EFE2Q30196753-8964B34F-C8EC-43FD-92E8-9D52164E5F5DQ30364140-A91C5898-0078-4848-8288-D078496B204EQ30392979-8C928260-9BBE-4067-AEED-0CF63777E3FCQ30686948-BE56CB05-524A-4A69-8025-4A5E8EBB05E0Q31120060-42F64E43-FD52-4738-97A5-BD1E749200B5Q31125771-178C6ED9-6E69-4E78-B4A9-FA857F3C0896Q33569607-B9E0EE49-8076-429D-A496-E3ADAB57FF06Q33607607-AF87DC42-042B-4EF8-B533-A836384870D1Q33646688-0FF9291B-15E6-4B3C-97CE-47636AFEDB4CQ33741482-6C32BAFE-D517-437D-AAA8-356BC3AD9A53Q33867749-7380E1D3-73D8-49EB-A340-2F567BAC718BQ33871384-BE015B72-F7D0-4A7B-92A1-F2076443CE32Q33920084-A38D958C-B509-4F4A-A2E6-C5E3BF8E0C25Q33925054-2793EED8-2F01-43B2-B6C3-6CB057C964EFQ34004933-B65972BB-60F8-4746-A88E-481D013C5079Q34277912-F9B92A28-266B-4A42-8BB5-F6854B2898FDQ34398784-2D3D9459-C793-4688-97A7-59EAA600C0C9Q34421046-6F56749B-CBE8-41AD-93F8-5FAEBF750DF7Q34425731-23C6C8C2-51B4-418C-9A82-F10976097330Q34450363-A5D24613-26DC-4DFD-934A-F16A62023351Q34586921-93E25B14-C087-419B-88DF-91CBE3205413Q34603093-F9C875B6-991F-453F-B18E-E4E4F142C34AQ34671155-FED5C92C-6279-42B0-9264-1E06C9DAC7F6Q34699172-ACEC93DC-895E-46D5-B4DB-0A041B8BF283Q34699248-0D10335F-C609-4330-8E02-EA35E03E58B9Q34789357-5DD508B9-4347-439D-9ABE-1C019B6E51FFQ34990281-C1DAE5E4-DF19-45FD-97BA-4FB408006178Q35088520-462FBC76-0FAE-4562-AEC3-CB8F52106186Q35101926-3B9FC45A-44B1-45D5-81D0-432C3584FF59Q35186213-D33B472F-6B18-47F9-8056-562B6EBB0968Q35532541-D9680DD3-4EE2-4F28-87C8-5F0E9F21EB48Q35606577-4B60074E-5025-4934-8869-8C89C8C3BE07Q35641817-DC8BD99E-916E-4D56-830E-9E845659DDC9Q35671852-B9867906-06A1-4A84-B118-B09BE07575BF
P2860
Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus: Abbreviated Report of a WHO Consultation
description
2011 nî lūn-bûn
@nan
2011 թուականին հրատարակուած գիտական յօդուած
@hyw
2011 թվականին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Use of Glycated Haemoglobin (H ...... d Report of a WHO Consultation
@ast
Use of Glycated Haemoglobin (H ...... d Report of a WHO Consultation
@en
type
label
Use of Glycated Haemoglobin (H ...... d Report of a WHO Consultation
@ast
Use of Glycated Haemoglobin (H ...... d Report of a WHO Consultation
@en
prefLabel
Use of Glycated Haemoglobin (H ...... d Report of a WHO Consultation
@ast
Use of Glycated Haemoglobin (H ...... d Report of a WHO Consultation
@en
P1476
Use of Glycated Haemoglobin (H ...... d Report of a WHO Consultation
@en
P407
P577
2011-01-01T00:00:00Z